Vincent JL, Sun Q, Dubois MJ: Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis. 2002, 34: 1084-1093. 10.1086/339549.
Article
CAS
PubMed
Google Scholar
Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanasia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010, 14: R96-10.1186/cc9031.
Article
PubMed
PubMed Central
Google Scholar
Bouchon A, Facchetti F, Welgant MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001, 410: 1103-1107. 10.1038/35074114.
Article
CAS
PubMed
Google Scholar
Colonna M, Facchetti F: TREM-1 (trigerring receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003, 187 (Suppl 2): 397-401.
Article
Google Scholar
Ford JW, McVicar DW: TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009, 21: 38-46. 10.1016/j.coi.2009.01.009.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tessarz A, Cerwenka A: The TREM-1/DAP12 pathway. Immunoogy Letters. 2008, 116: 111-116. 10.1016/j.imlet.2007.11.021.
Article
CAS
Google Scholar
Sharif O, Knapp S: From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunology. 2008, 213: 701-713.
CAS
Google Scholar
Klesney-Tait J, Turnbull IR, Cilonna M: The TREM receptor family and signal integration. Nat Immunol. 2006, 7: 1266-1273. 10.1038/ni1411.
Article
CAS
PubMed
Google Scholar
Radsak MP, Salih HR, Rammensee HR, Schild H: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 2004, 172: 4956-4963.
Article
CAS
PubMed
Google Scholar
Giamarellos-Bourboulis EJ, Tsangaris I, Kanni Th, Mouktaroudi M, Pantelidou I, Adamis G, Atmatzidis S, Chrisofos M, Evangelopoulou V, Frantzeskaki F, et al: Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infect. 2011, 77: 58-63. 10.1016/j.jhin.2010.07.026.
Article
CAS
PubMed
Google Scholar
Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M, Antonakos N, et al: Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care. 2011, 26: 331.e1-331.e7.
Article
Google Scholar
Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent J, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.
Article
PubMed
Google Scholar
Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.
Article
CAS
PubMed
Google Scholar
Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002, 165: 867-903.
Article
PubMed
Google Scholar
Vincent JL: Ventilator-associated pneumonia. J Hosp Infect. 2004, 57: 272-280. 10.1016/j.jhin.2003.06.001.
Article
PubMed
Google Scholar
Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5.
Article
CAS
PubMed
Google Scholar
Calandra T, Cohen J: The international Sepsis Forum Consensus definitions of infections in the intensive care unit. Crit Care Med. 2005, 33: 1639-48.
Article
Google Scholar
Vincent JL: Clinical sepsis and septic shock definition, diagnosis and management principles. Langenbecks Arch Surg. 2008, 393: 817-824. 10.1007/s00423-008-0343-1.
Article
PubMed
Google Scholar
Remick DJ: Pathophysiology of sepsis. Am J Pathol. 2007, 170: 1435-1444.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bouchon A, Dietrich J, Colonna M: Cutting edge. Inflammatory responses can be trigerred by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000, 164: 4991-4995.
Article
CAS
PubMed
Google Scholar
Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, Levy B: Surface trigerring receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 2005, 31: 594-597. 10.1007/s00134-005-2572-x.
Article
PubMed
Google Scholar
Dimopoulou I, Orfanos SE, Pelekanou A, Kotanidou A, Livaditi O, Augustatou C, Zervou M, Douka E, Theodorakopoulou M, Karagianni V, Douzinas E, Armaganidis A, Giamarellos-Bourboulis EJ: Serum of patients with septic shock stimulates the expression of TREM-1 on U937 monocytes. Inflamm Res. 2009, 58: 127-132. 10.1007/s00011-008-7039-4.
Article
CAS
PubMed
Google Scholar
Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a trigerring receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med. 2004, 141: 9-15.
Article
CAS
PubMed
Google Scholar
Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M: Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care. 2010, 25: 362.e1-e6. 10.1016/j.jcrc.2009.10.004.
Article
CAS
Google Scholar
Barraud D, Gibot S: Triggering receptor expressed on myeloid cells 1. Crit Care Clin. 2011, 27: 265-279. 10.1016/j.ccc.2010.12.006.
Article
CAS
PubMed
Google Scholar
Porfiridis I, Plachouras D, Karagianni V, Kotanidou A, Papiris S, Giamarellou H, Giamarellos-Bourboulis EJ: Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study. BMC Infectious Diseases. 2010, 10: 286-10.1186/1471-2334-10-286.
Article
Google Scholar
Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ: Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009, 13: R172-10.1186/cc8148.
Article
PubMed
PubMed Central
Google Scholar
Giamarelos-Bourboulis EJ, Zakynthinos S, Baziaka F, Papadomichelakis E, Virtzili S, Koutoukas P, Armaganidis A, Giamarellou H, Roussos C: Soluble trigerring receptor expressed on myeloid cells-1 as an anti-inflammatory mediator in sepsis. Intensive Care Med. 2006, 32: 237-243. 10.1007/s00134-005-0017-1.
Article
Google Scholar